Is low libido normal in women with polycystic ovary syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Low Libido in Women with PCOS

Low libido is common in women with PCOS, affecting approximately 28-58% of patients, and should be considered a recognized comorbidity rather than dismissed as "normal." 1, 2, 3

Prevalence and Clinical Significance

Sexual dysfunction, including reduced libido, occurs at significantly higher rates in PCOS compared to the general population:

  • Sexual dysfunction affects 27-58% of women with PCOS, with desire and arousal being the most commonly affected domains (impacting up to 99% of those with dysfunction). 1, 2, 3
  • The desire domain specifically shows impairment in the vast majority of affected women, making low libido one of the most prevalent sexual complaints. 3
  • Marital sexual dysfunction is diagnosed in 28.6% of women with PCOS versus only 10.5% of healthy controls, representing a nearly three-fold increase. 2

Key Contributing Factors

Hormonal Mechanisms

The relationship between androgens and libido in PCOS is paradoxical and counterintuitive:

  • Women with PCOS whose testosterone levels are in the normal range (not elevated) are at increased risk for sexual dysfunction. 4
  • Conversely, women with testosterone levels >1 standard deviation above the mean have significantly better sexual functioning compared to those with normal or low-normal levels. 4
  • This suggests that the hyperandrogenism characteristic of PCOS (present in 75% of cases) may not directly cause low libido, and other mechanisms predominate. 5, 4

Physical and Metabolic Factors

Body composition and metabolic health significantly impact sexual function:

  • Increasing BMI is associated with significant reduction in sexual desire and arousal, independent of other PCOS features. 4, 3
  • Central obesity exacerbates metabolic, reproductive, and psychological features of PCOS, all of which can indirectly affect libido. 6, 7
  • Weight gain is a major trigger for PCOS symptom worsening in genetically susceptible women. 5, 7

Psychological and Appearance-Related Factors

The visible manifestations of PCOS create substantial psychological burden:

  • Hirsutism severity has a significant negative effect on sexual function across all domains (p<0.001 for total sexual function scores). 3
  • Quality of life parameters are significantly lower in PCOS women, particularly in emotional wellbeing, energy/fatigue, and social functioning—all of which correlate with sexual desire. 2
  • Anxiety, depression, and eating disorders are prevalent in PCOS and significantly impact quality of life and sexual function. 7

Treatment Approaches That Improve Libido

Lifestyle Modification (First-Line)

Intensive lifestyle modification alone or combined with hormonal contraceptives improves sexual desire in women with PCOS. 1

  • After 16 weeks of intensive lifestyle intervention, the desire domain subscore significantly improved. 1
  • Among women meeting criteria for sexual dysfunction at baseline (FSFI score ≤26.55), lifestyle modification produced measurable improvement in overall sexual function scores. 1
  • The mechanism is likely multifactorial, involving weight loss, improved metabolic parameters, enhanced body image, and reduced psychological distress. 1

Combined Approach

  • The combination of intensive lifestyle modification plus oral contraceptive pills produces the greatest improvement in sexual desire, though OCPs alone do not alter sexual function scores. 1
  • This suggests that addressing the metabolic and psychological components is more critical than hormonal manipulation alone. 1

Critical Clinical Pitfalls

Diagnostic Confusion with FHA-PCOM

Be aware that functional hypothalamic amenorrhea with polycystic ovarian morphology (FHA-PCOM) can mimic PCOS:

  • 41.9-46.7% of women with FHA have polycystic ovarian morphology on ultrasound, which can lead to misdiagnosis as PCOS. 6
  • FHA-PCOM patients have signs of estrogen deficiency, low or normal BMI, and history of low energy availability or stress—features distinct from typical PCOS. 6
  • Estrogen deficiency in FHA would be expected to cause low libido through different mechanisms than PCOS. 6

Partner Discordance

  • The discrepancy in arousal between women with PCOS and their male partners is substantial (mean difference -2.32, Cohen's d = -1.26), indicating that "normal" sexual function scores in PCOS women may not reflect adequate sexual functioning within the relationship context. 8

Screening Recommendation

All women with PCOS should be screened for sexual dysfunction using a validated questionnaire such as the Female Sexual Function Index (FSFI) or Changes in Sexual Functioning Questionnaire (CSFQ-14). 3

  • This screening should occur at initial diagnosis and periodically during follow-up, as sexual dysfunction represents a significant quality of life issue that warrants targeted intervention. 3
  • The importance and level of sexual satisfaction correlate with almost all domains of sexual function, making these simple questions valuable screening tools. 8

References

Research

Sexual function in women with polycystic ovary syndrome.

The journal of sexual medicine, 2012

Guideline

PCOS-Related Hirsutism Pathophysiology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Features and Diagnosis of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.